SCFAs also known to have downstream effects on the endocrine function influencing the secretion of satiety signals hormones such as GLP-1 and PPY, further affecting insulin resistance and lipid metabolism disorder which accompany with NAFLD most of the time (Canfora et al., 2019). Here, GCG is linked to metabolic dysfunction-associated steatotic liver disease.